{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T20:53:30Z","timestamp":1727124810865},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00106-021-01144-8","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T17:02:39Z","timestamp":1643043759000},"page":"239-248","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HNO-\u00e4rztliche Krankheitsbilder in der Schwangerschaft\u00a0\u2013 welche Medikamente sind zul\u00e4ssig?","Otorhinolaryngological diseases in pregnancy\u2014which drugs are approved?"],"prefix":"10.1007","volume":"70","author":[{"given":"W. E.","family":"Paulus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lindemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Friebe-Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"issue":"4","key":"1144_CR1","doi-asserted-by":"publisher","first-page":"e0194986","DOI":"10.1371\/journal.pone.0194986","volume":"13","author":"JK Morris","year":"2018","unstructured":"Morris\u00a0JK, Springett\u00a0AL, Greenlees\u00a0R, Loane\u00a0M, Addor\u00a0MC, Arriola\u00a0L, Barisic\u00a0I, Bergman\u00a0JEH, Csaky-Szunyogh\u00a0M, Dias\u00a0C, Draper\u00a0ES, Garne\u00a0E, Gatt\u00a0M, Khoshnood\u00a0B, Klungsoyr\u00a0K, Lynch\u00a0C, McDonnell\u00a0R, Nelen\u00a0V, Neville\u00a0AJ, O\u2019Mahony\u00a0M, Pierini\u00a0A, Queisser-Luft\u00a0A, Randrianaivo\u00a0H, Rankin\u00a0J, Rissmann\u00a0A, Kurinczuk\u00a0J, Tucker\u00a0D, Verellen-Dumoulin\u00a0C, Wellesley\u00a0D, Dolk\u00a0H (2018) Trends in congenital anomalies in Europe from 1980 to 2012. PLoS ONE 13(4):e194986","journal-title":"PLoS ONE"},{"issue":"38","key":"1144_CR2","first-page":"A 2464","volume":"103","author":"A Quei\u00dfer-Luft","year":"2006","unstructured":"Quei\u00dfer-Luft\u00a0A, Spranger\u00a0J (2006) Fehlbildungen bei Neugeborenen. Dtsch Arztebl 103(38):A 2464\u2013A 2471","journal-title":"Dtsch Arztebl"},{"key":"1144_CR3","volume-title":"Drugs in pregnancy and lactation","author":"GG Briggs","year":"2021","unstructured":"Briggs\u00a0GG, Freeman\u00a0RK, Towers\u00a0CV, Forinash\u00a0AB (2021) Drugs in pregnancy and lactation, 12.\u00a0Aufl. Wolters Kluwer, Philadelphia","edition":"12"},{"key":"1144_CR4","volume-title":"Arzneimittel in Schwangerschaft und Stillzeit","author":"C Schaefer","year":"2012","unstructured":"Schaefer\u00a0C, Spielmann\u00a0H, Vetter\u00a0K, Weber-Schoendorfer\u00a0C (2012) Arzneimittel in Schwangerschaft und Stillzeit, 8.\u00a0Aufl. Urban & Fischer, M\u00fcnchen","edition":"8"},{"key":"1144_CR5","doi-asserted-by":"crossref","DOI":"10.52778\/9783804742857","volume-title":"Arzneimittel in der Schwangerschaft und Stillzeit. Ein Leitfaden f\u00fcr \u00c4rzte und Apotheker","author":"K Friese","year":"2021","unstructured":"Friese\u00a0K, M\u00f6rike\u00a0K, Neumann\u00a0G, Paulus\u00a0WE (2021) Arzneimittel in der Schwangerschaft und Stillzeit. Ein Leitfaden f\u00fcr \u00c4rzte und Apotheker, 9.\u00a0Aufl. Wissenschaftliche Verlagsgesellschaft, Stuttgart","edition":"9"},{"key":"1144_CR6","doi-asserted-by":"publisher","first-page":"e0219095","DOI":"10.1371\/journal.pone.0219095","volume":"14","author":"A B\u00e9rard","year":"2019","unstructured":"B\u00e9rard\u00a0A, Abbas-Chorfa\u00a0F, Kassai\u00a0B, Vial\u00a0T, Nguyen\u00a0KA, Sheehy\u00a0O, Schott\u00a0AM (2019) The French pregnancy cohort: medication use during pregnancy in the French population. PLoS ONE 14:e219095","journal-title":"PLoS ONE"},{"key":"1144_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00106-012-2517-y","volume":"60","author":"S Gronau","year":"2012","unstructured":"Gronau\u00a0S, Neumann\u00a0A (2012) Medikament\u00f6se Therapie w\u00e4hrend der Schwangerschaft. HNO 60:637\u2013648","journal-title":"HNO"},{"key":"1144_CR8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1053\/j.semperi.2015.08.009","volume":"39","author":"C Chambers","year":"2015","unstructured":"Chambers\u00a0C (2015) Over-the-counter medications: risk and safety in pregnancy. Semin Perinatol 39:541\u2013544","journal-title":"Semin Perinatol"},{"key":"1144_CR9","doi-asserted-by":"publisher","first-page":"B14","DOI":"10.1016\/j.ajog.2017.01.021","volume":"216","author":"Society for Maternal-Fetal Medicine (SMFM) Publications Committee","year":"2017","unstructured":"Society for Maternal-Fetal Medicine (SMFM) Publications Committee (2017) Prenatal acetaminophen use and outcomes in children. Am J Obstet Gynecol 216:B14\u2013B15","journal-title":"Am J Obstet Gynecol"},{"key":"1144_CR10","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1002\/ppul.25595","volume":"56","author":"M Singh","year":"2021","unstructured":"Singh\u00a0M, Varukolu\u00a0S, Chauhan\u00a0A, Jaiswal\u00a0N, Pradhan\u00a0P, Mathew\u00a0JL, Singh\u00a0M (2021) Paracetamol exposure and asthma: what does the evidence say? An overview of systematic reviews. Pediatr Pulmonol 56:3189\u20133199","journal-title":"Pediatr Pulmonol"},{"key":"1144_CR11","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00103-018-2798-8","volume":"61","author":"C Schaefer","year":"2018","unstructured":"Schaefer\u00a0C (2018) Arzneimitteltherapiesicherheit in der Schwangerschaft \u2013 eine besondere Herausforderung. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 61:1129\u20131138","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"1144_CR12","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/phar.1649","volume":"35","author":"PB Bookstaver","year":"2015","unstructured":"Bookstaver\u00a0PB, Bland\u00a0CM, Griffin\u00a0B, Stover\u00a0KR, Eiland\u00a0LS, McLaughlin\u00a0M (2015) A review of antibiotic use in pregnancy. Pharmacotherapy 35:1052\u20131062","journal-title":"Pharmacotherapy"},{"key":"1144_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007575.pub2","author":"A Matthews","year":"2015","unstructured":"Matthews\u00a0A, Haas\u00a0DM, O\u2019Math\u00fana\u00a0DP, Dowswell\u00a0T (2015) Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD007575.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1144_CR14","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1097\/AOG.0000000000002456","volume":"131","author":"American College of Obstetricians and Gynecologists (ACOG)","year":"2018","unstructured":"American College of Obstetricians and Gynecologists (ACOG), Committee on Practice Bulletins-Obstetrics (2018) ACOG practice bulletin no. 189: nausea and vomiting of pregnancy. Obstet Gynecol 131(1):e15\u2013e30","journal-title":"Obstet Gynecol"},{"key":"1144_CR15","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1055\/s-0033-1358772","volume":"31","author":"J Chin","year":"2014","unstructured":"Chin\u00a0J, Gregor\u00a0S, Persaud\u00a0N (2014) Re-analysis of safety data supporting doxylamine use for nausea and vomiting of pregnancy. Am J Perinatol 31:701\u2013710","journal-title":"Am J Perinatol"},{"key":"1144_CR16","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/bcpt.13541","volume":"128","author":"P Damkier","year":"2021","unstructured":"Damkier\u00a0P, Kaplan\u00a0YC, Shechtman\u00a0S, Diav-Citrin\u00a0O, Cassina\u00a0M, Weber-Schoendorfer\u00a0C (2021) Ondansetron in pregnancy revisited: assessment and pregnancy labelling by the European medicines agency (EMA) & pharmacovigilance risk assessment committee (PRAC). Basic Clin Pharmacol Toxicol 128:579\u2013582","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"Suppl 1","key":"1144_CR17","first-page":"1","volume":"69","author":"British Thoracic Society","year":"2014","unstructured":"British Thoracic Society, Scottish Intercollegiate Guidelines Network (2014) British guideline on the management of asthma. Thorax 69(Suppl 1):1\u2013192","journal-title":"Thorax"},{"key":"1144_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1055\/s-0042-110325","volume":"221","author":"U Friebe-Hoffmann","year":"2017","unstructured":"Friebe-Hoffmann\u00a0U, Lindemann\u00a0J (2017) Update Schwangerschaftsrhinitis. Z\u00a0Geburtshilfe Neonatol 221:59\u201366","journal-title":"Z Geburtshilfe Neonatol"},{"key":"1144_CR19","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1185\/030079905X50570","volume":"21","author":"PA Gluck","year":"2005","unstructured":"Gluck\u00a0PA, Gluck\u00a0JC (2005) A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide. Curr Med Res Opin 21:1075\u20131084","journal-title":"Curr Med Res Opin"},{"key":"1144_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4193\/Rhino15.228","volume":"54","author":"D Lal","year":"2016","unstructured":"Lal\u00a0D, Jategaonkar\u00a0AA, Borish\u00a0L, Chambliss\u00a0LR, Gnagi\u00a0SH, Hwang\u00a0PH, Rank\u00a0MA, Stankiewicz\u00a0JA, Lund\u00a0VJ (2016) Management of rhinosinusitis during pregnancy: systematic review and expert panel recommendations. Rhinology 54:99\u2013104","journal-title":"Rhinology"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-021-01144-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00106-021-01144-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-021-01144-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T20:17:04Z","timestamp":1726517824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00106-021-01144-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1144"],"URL":"https:\/\/doi.org\/10.1007\/s00106-021-01144-8","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"type":"print","value":"0017-6192"},{"type":"electronic","value":"1433-0458"}],"subject":[],"published":{"date-parts":[[2022,1,24]]},"assertion":[{"value":"22 December 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>W.E.\u00a0Paulus<\/b>: A.\u00a0Finanzielle Interessen: Referentenhonorare f\u00fcr Fortbildungsveranstaltungen zu Risiken einer Arzneimitteltherapie in Schwangerschaft und Stillzeit von Bezirks\u00e4rztekammer Nordw\u00fcrttemberg, ITF Pharma GmbH, Janssen-Cilag GmbH, Landesapothekerkammer Baden-W\u00fcrttemberg, med update GmbH, PHOENIX Pharmahandel GmbH & Co KG, RG \u00c4rztefortbildung GmbH, UCB Pharma GmbH, MSD Sharp & Dohme GmbH, Abbvie Deutschland GmbH & Co. KG.\u00a0\u2013 Einmaliges Beratungsgespr\u00e4ch zu Risiken eines Medikaments in der Schwangerschaft bei Desitin Arzneimittel GmbH.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Leiter der Beratungsstelle f\u00fcr Reproduktionstoxikologie\/Oberarzt der Universit\u00e4tsfrauenklinik Ulm | Mitgliedschaft: Deutsche Gesellschaft f\u00fcr Gyn\u00e4kologie und Geburtshilfe, Deutsche Gesellschaft f\u00fcr Ultraschall in der Medizin, European Network of Teratology Information Services, Deutsche Gesellschaft f\u00fcr Perinatale Medizin, Deutsches Netzwerk Evidenzbasierte Medizin, Deutsche Gesellschaft f\u00fcr Pr\u00e4natal- und Geburtsmedizin, Bayerische Gesellschaft f\u00fcr Geburtshilfe und Frauenheilkunde.<b>J.\u00a0Lindemann<\/b>: A.\u00a0Finanzielle Interessen: J.\u00a0Lindemann gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Oberarzt der HNO-Universit\u00e4tsklinik Ulm | Mitgliedschaften: Deutsche HNO-Gesellschaft, Deutsche Gesellschaft f\u00fcr Schlafmedizin.<b>U.\u00a0Friebe-Hoffmann<\/b>: A.\u00a0Finanzielle Interessen: Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: Hebammenhochschule Heidenheim f\u00fcr Dozentent\u00e4tigkeit, Erstattung der Kongressgeb\u00fchren f\u00fcr DGPM, Ultraschall at 2021, diverse DEGUM Zertifizierungskurse etc.\u00a0\u2013 Kostenerstattung erfolgte \u00fcber das Universit\u00e4tsklinikum ULM, medizinische Fakult\u00e4t als mein Arbeitgeber (Reise- oder \u00dcbernachtungskosten, bezahlte Teilnehmergeb\u00fchren).\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Ober\u00e4rztin in der Universit\u00e4tsfrauenklink Ulm | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Gyn\u00e4kologie und Geburtshilfe (DGGG), Arbeitsgemeinschaft Materno-Fetale Medizin (AGMFM) und Arbeitsgemeinschaft f\u00fcr Ultraschalldiagnostik in Gyn\u00e4kologie und Geburtshilfe (ARGUS), Deutsche Gesellschaft f\u00fcr Perinatale Medizin (DGPM), Deutsche Gesellschaft f\u00fcr Ultraschall in der Medizin (DEGUM).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}